TJG IS INDEXED IN WEB OF SCIENCE AND PUBMED IMPACT FACTOR: 1.2
Turkish Journal of Gastroenterology
  1. Home
  2. Search
Search Results
Total of 5 results
Ranking
Release Date Sort Sort Article Type

Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

Bilgehan Aygen, Ahmet Muzaffer Demir, Mahmut Gümüş, Oğuz Karabay, Sabahattin Kaymakoğlu, Aydın Şeref Köksal, İftihar Köksal, Necati Örmeci, Fehmi Tabak

(Turk J Gastroenterol 2018; 29: 259-269) DOI: 10.5152/tjg.2018.18263

Abstract Full Text ( PDF) Related Articles

Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, The Study Group for Viral Hepatitis of The Turkish Society of Clinical Microbiology and Infectious Diseases

(Turk J Gastroenterol 2019; 30: 10-15) DOI: 10.5152/tjg.2019.07

Abstract Full Text ( PDF) Related Articles

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, İlhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Sami Kınıklı, Faruk Karakeçili, Gökmen Zararsız, The Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases*

(Turk J Gastroenterol 2020; 31: 305-317) DOI: 10.5152/tjg.2020.19197

Abstract Full Text ( PDF) Related Articles
EISSN 2148-5607